Free Trial

Thompson Siegel & Walmsley LLC Acquires 2,332,388 Shares of Clarivate Plc (NYSE:CLVT)

Clarivate logo with Computer and Technology background

Thompson Siegel & Walmsley LLC increased its position in Clarivate Plc (NYSE:CLVT - Free Report) by 31.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,726,504 shares of the company's stock after acquiring an additional 2,332,388 shares during the quarter. Thompson Siegel & Walmsley LLC owned about 1.46% of Clarivate worth $55,344,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Evermay Wealth Management LLC bought a new position in Clarivate in the 1st quarter worth about $31,000. Nisa Investment Advisors LLC bought a new position in shares of Clarivate in the second quarter worth approximately $26,000. J.W. Cole Advisors Inc. bought a new position in shares of Clarivate in the first quarter worth approximately $76,000. Forum Financial Management LP purchased a new stake in Clarivate in the second quarter valued at approximately $75,000. Finally, Headlands Technologies LLC lifted its position in Clarivate by 749.2% during the second quarter. Headlands Technologies LLC now owns 14,632 shares of the company's stock valued at $83,000 after purchasing an additional 12,909 shares during the last quarter. Hedge funds and other institutional investors own 85.72% of the company's stock.

Clarivate Trading Up 4.1 %

CLVT stock traded up $0.26 on Friday, reaching $6.57. The company's stock had a trading volume of 3,316,476 shares, compared to its average volume of 4,358,022. The business has a fifty day simple moving average of $6.35 and a two-hundred day simple moving average of $6.45. Clarivate Plc has a 12-month low of $4.97 and a 12-month high of $9.60. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.90 and a current ratio of 0.90. The firm has a market cap of $4.39 billion, a PE ratio of -3.96, a PEG ratio of 3.24 and a beta of 1.17.

Clarivate (NYSE:CLVT - Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.18 by $0.02. The firm had revenue of $650.30 million for the quarter, compared to analysts' expectations of $651.94 million. Clarivate had a negative net margin of 46.53% and a positive return on equity of 10.01%. The company's quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.16 EPS. As a group, research analysts forecast that Clarivate Plc will post 0.64 EPS for the current year.

Insider Transactions at Clarivate

In other news, Director Saurabh Saha sold 17,646 shares of the business's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the transaction, the director now owns 23,741 shares in the company, valued at $160,251.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Clarivate news, Director Andrew Miles Snyder bought 28,938 shares of the business's stock in a transaction that occurred on Thursday, August 8th. The stock was bought at an average cost of $5.49 per share, for a total transaction of $158,869.62. Following the completion of the transaction, the director now owns 288,334 shares of the company's stock, valued at approximately $1,582,953.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Saurabh Saha sold 17,646 shares of the company's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $6.75, for a total value of $119,110.50. Following the completion of the sale, the director now owns 23,741 shares of the company's stock, valued at $160,251.75. The disclosure for this sale can be found here. 22.77% of the stock is owned by insiders.

Wall Street Analyst Weigh In

CLVT has been the topic of a number of research reports. Barclays lowered their price target on Clarivate from $6.00 to $5.00 and set an "underweight" rating on the stock in a research report on Wednesday, August 7th. Royal Bank of Canada dropped their target price on Clarivate from $8.00 to $7.00 and set a "sector perform" rating for the company in a research report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, Clarivate presently has a consensus rating of "Hold" and an average target price of $7.75.

Read Our Latest Report on Clarivate

About Clarivate

(Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

See Also

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Should you invest $1,000 in Clarivate right now?

Before you consider Clarivate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.

While Clarivate currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Top Stock Picks Amid Tech Market Meltdown

Top Stock Picks Amid Tech Market Meltdown

Despite warnings of an AI bubble, we discuss why this could be an opportunity to buy quality tech names at attractive prices.

Recent Videos

Why Congress Is Betting Big on Chubb: The Underrated Insurance Stock
AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch
Why Congress Is Betting Big on Broadcom in 2024

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines